The incidence of SAE is known to be elevated in diabetic patients [33], possibly due to chronic hyperglycemia and insulin resistance, which can exacerbate neuroinflammation, disrupt mitochondrial function in the hippocampus, and lower nerve growth factor (NGF) levels, thereby worsening neurological outcomes [34]. This evidence concerns the gene NGF and Insulin resistance.